Russia aims to produce ‘millions’ of virus doses by 2021

Russia aims to produce ‘millions’ of virus doses by 2021
The country is pushing ahead with several vaccine prototypes and one prepared at the Gamaleya institute in Moscow has reached advanced stages of development. (File/AFP)
Short Url
Updated 03 August 2020

Russia aims to produce ‘millions’ of virus doses by 2021

Russia aims to produce ‘millions’ of virus doses by 2021
  • The Gamaleya institute came under fire after researchers and directors injected themselves with the prototype months ago
  • Scientists have told AFP that Russia will struggle to adapt the vaccine to mass production because the country lacks raw materials, adequate facilities and experience

MOSCOW: Russia said Monday it aims to launch mass production of a coronavirus vaccine next month and turn out “several million” doses per month by next year.
The country is pushing ahead with several vaccine prototypes and one prepared at the Gamaleya institute in Moscow has reached advanced stages of development.
“We are very much counting on starting mass production in September,” industry minister Denis Manturov said in an interview published by TASS news agency.
“We will be able to ensure production volumes of several hundred thousand a month, with an eventual increase to several million by the start of next year,” he said, adding that one developer is preparing production technology at three locations in central Russia.
Health Minister Mikhail Murashko on Saturday said the Gamaleya vaccine had “completed clinical trials” and that documents were being prepared to register it with the state.
Another vaccine, developed by Siberia-based Vektor lab, is currently undergoing clinical trials and two more will begin human testing within the next two months, Murashko said.
Gamaleya’s vaccine is a so-called viral vector vaccine, meaning it employs another virus to carry the DNA encoding of the needed immune response into cells.
Gamaleya’s vaccine employs the adenovirus, a similar technology to the coronavirus vaccine prototype developed by China’s CanSino, currently in the advanced stage of clinical trials.
The Gamaleya institute came under fire after researchers and directors injected themselves with the prototype months ago, with specialists criticizing the move as an unorthodox and rushed way of starting human trials.
Scientists have told AFP that Russia will struggle to adapt the vaccine to mass production because the country lacks raw materials, adequate facilities and experience, particularly with advanced technology like viral vector.
Some Russian officials have boasted that the country will be the first to come up with the vaccine, even comparing it to the space race to produce the first satellite in the Soviet era.
Moscow has dismissed allegations from the UK, the United States and Canada that a hacking group linked to Russian intelligence services tried to steal information about a coronavirus vaccine from labs in the West.
Russia’s coronavirus caseload is currently fourth in the world after the United States, Brazil and India.


Bomb kills two policemen in Afghan capital

Bomb kills two policemen in Afghan capital
Updated 16 January 2021

Bomb kills two policemen in Afghan capital

Bomb kills two policemen in Afghan capital
  • Two policemen were killed and one wounded
  • The two warring sides are currently in the Qatari capital Doha discussing the agenda items of the talks

KABUL: A roadside bomb targeting a police vehicle in the Afghan capital killed two policemen Saturday, officials said, as violence continues unabated in Afghanistan despite peace talks between the Taliban and government.
The vehicle carrying the policemen was struck by the bomb in the center of the capital on the road to the prestigious Kabul University, police spokesman Ferdaws Faramarz said.
Two policemen were killed and one wounded, Faramarz said.
Violence has surged across the country in recent months, especially in Kabul which is also rocked by a new trend of targeted killings that has sown fear in the city.
The bloodshed comes even as the Taliban and government negotiators engage in peace talks to end the nearly two decade war in the country.
The two warring sides are currently in the Qatari capital Doha discussing the agenda items of the talks.